Patent · US Active

Variants of Cpf1 (Cas12a) with altered PAM specificity

US11591589B2 · kind B2 · utility

1Cited by
0References
36Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 23, 2018
Grant dateFeb 28, 2023
Priority date
Expiry dateFeb 26, 2040

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Engineered CRISPR from Prevotella and Francisella 1 (Cpf1) nucleases with improved targeting range and enhanced on-target activity, and their use in genomic engineering, epigenomic engineering, base editing, genome targeting, genome editing, and in vitro diagnostics.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.